Data & Analytics

How data regulation could be good for marketing post-Cambridge Analytica

How data regulation could be good for marketing post-Cambridge Analytica

By

Stuart Ingis on the benefits of showing the public how advertisers and marketers use data and creating a global regulatory framework.

Wendy Blackburn, Intouch Solutions

Wendy Blackburn, Intouch Solutions

Wendy Blackburn is EVP, marketing and communications of Intouch Solutions.

Evidence-based patient access programs

Evidence-based patient access programs

By

At the Asembia Specialty Pharma summit, speakers described a healthcare ecosystem in which specialty products will represent nearly half of all drug spending.

Interview | Paul LeVine, TrialCard

Interview | Paul LeVine, TrialCard

By

Paul LeVine, VP, Analytic Services for TrialCard, describes proven strategies that prevent patient adherence fall off, driven by evidenced-based design and patient engagement programs.

Data-driven. Obsessive. A little pushy. Meet this year's Top 40 Healthcare Transformers

Data-driven. Obsessive. A little pushy. Meet this year's Top 40 Healthcare Transformers

By

Those on the vanguard of transformation include a number of upstarts and veteran gurus taking on historic challenges plaguing health data.

Sundeep Bhan, Prognos

Sundeep Bhan, Prognos

Sundeep Bhan is cofounder and CEO of Prognos.

Wout Brusselaers, Deep 6 AI

Wout Brusselaers, Deep 6 AI

Wout Brusselaers is CEO of Deep 6 AI.

Amy Foley, Johnson & Johnson

Amy Foley, Johnson & Johnson

Amy Foley is VP, product innovation and delivery at Johnson & Johnson.

Cliff Jones, AllazoHealth

Cliff Jones, AllazoHealth

Cliff Jones is CEO of AllazoHealth.

Duncan Arbour, Syneos Health Communications

Duncan Arbour, Syneos Health Communications

Duncan Arbour is SVP of innovation at Syneos Health Communications.

Susan Dorfman, CMI/Compas

Susan Dorfman, CMI/Compas

Susan Dorfman is chief commercial officer of CMI/Compas.

Greg Matthews, W2O Group

Greg Matthews, W2O Group

Greg Matthews is managing director, healthcare and founder, MDigitalLife at W2O Group.

Donna Murphy, Havas Health & You

Donna Murphy, Havas Health & You

Donna Murphy is global CEO of Havas Health & You.

Marcus Sigurdsson, McCann Health

Marcus Sigurdsson, McCann Health

Marcus Sigurdsson is global chief digital officer of McCann Health.

IPG CEO praises 'range of agencies' for Q1 revenue growth

IPG CEO praises 'range of agencies' for Q1 revenue growth

The strong start to 2018 means the firm is on track to hit financial targets for the year, said Michael Roth.

Infographic | AI's impact on patients and caregivers

Infographic | AI's impact on patients and caregivers

By

Caregivers and patients predict how the use of AI will affect them.

The Cambridge Analytica mess: What does it mean for pharma?

The Cambridge Analytica mess: What does it mean for pharma?

What happens in the world of Facebook cannot be ignored in pharma marketing. It increasingly lives in a world of data that is highly sensitive and must be managed well.

In [Insert Company Here] We Trust?

In [Insert Company Here] We Trust?

Whether it's data or marketing dollars, there should be no surprises when you partner with a company.

Understanding FDA's Blueprint for Transparency

Understanding FDA's Blueprint for Transparency

The Food and Drug Administration regulates more than a third of the U.S. economy. And its new commissioner, Scott Gottlieb, is trying to shake up how it does so.

High five: How these companies are leveraging data to engage A-list HCPs

High five: How these companies are leveraging data to engage A-list HCPs

By

In the past, pharma hasn't used data effectively to engage its A-list HCPs. Five companies hope to change that.

Get to know your data scientist: Four data aces share their knowledge

Get to know your data scientist: Four data aces share their knowledge

By

Four data aces share their backgrounds, inspirations, and guiding philosophies

Machine Learning Can Decipher Data

Machine Learning Can Decipher Data

As researchers and analysts, we interact with a wide array of market research pros in the health and wellness space.

Five things for pharma marketers to know: Thursday, January 11, 2018

Five things for pharma marketers to know: Thursday, January 11, 2018

By

Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations

Bank brand creates own algorithm to avoid YouTube ad pitfalls

Bank brand creates own algorithm to avoid YouTube ad pitfalls

By

US bank JPMorgan Chase has returned to advertising on YouTube only after developing its own algorithm that ensures its ads are not placed around questionable content.

Study says drug development costs much less than previously estimated

Study says drug development costs much less than previously estimated

By

New research suggests that the oft-cited $2.6 billion estimate for bringing a drug to market is significantly overstated.

Roundtable: Market access takes center stage

Roundtable: Market access takes center stage

By

Participants in this roundtable explore how digital forms of data are poised to illuminate the reimbursement pathway, as market access gets its closeup.

Five things for pharma marketers to know: Friday, July 28, 2017

Five things for pharma marketers to know: Friday, July 28, 2017

By

Drugmakers inconsistently share clinical trial data; AstraZeneca's share price falls after Mystic results; some pregnancy apps share info with marketers

Bayer aims to drive patient-HCP dialogue with data-sharing app for MS

Bayer aims to drive patient-HCP dialogue with data-sharing app for MS

By

The FDA-approved app will allow MS patients to share their medication injection history with HCPs.

4 Ways to Help Pharma Understand and Better Use Big Data

4 Ways to Help Pharma Understand and Better Use Big Data

As drugmakers hire economists and pharmacologists to better grapple with big data, how can ad agencies ensure they're not left behind?

Five things for pharma marketers to know: Thursday, May 25, 2017

Five things for pharma marketers to know: Thursday, May 25, 2017

By

Fitness trackers do not reliably track calories, docs find; health-tech startups face market uncertainty; FDA adcom votes in favor of Puma breast-cancer drug